Article Information
History
- August 30, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Lauren E. Chan1,
- Elena Casiraghi2,
- Bryan Laraway3,
- Ben Coleman4,
- Hannah Blau4,
- Adnin Zaman5,
- Nomi Harris6,
- Kenneth Wilkins7,
- Michael Gargano4,
- Giorgio Valentini2,
- David Sahner8,
- Melissa Haendel3,
- Peter N. Robinson4,9,
- Carolyn Bramante10,
- Justin Reese6,* and
- the N3C consortium
- 1College of Public Health and Human Sciences, Oregon State University, Corvallis, OR, USA
- 2AnacletoLab, Dipartimento di Informatica, Università degli Studi di Milano, Italy
- 3University of Colorado Anschutz Medical Campus, Aurora, CO, USA
- 4The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT, USA
- 5Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
- 6Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA
- 7Biostatistics Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
- 8Axle Informatics, Rockville, MD, USA
- 9Institute for Systems Genomics, University of Connecticut, Farmington, CT, USA
- 10Division of General Internal Medicine, University of Minnesota, Minneapolis, MN, USA
- ↵*To whom correspondence should be addressed, Lawrence Berkeley National Laboratory, 717 Potter St., Berkeley, CA 94710, justinreese{at}lbl.gov.
Posted August 30, 2022.
Metformin is Associated with Reduced COVID-19 Severity in Patients with Prediabetes
